Another study by Taniguchi et al. also reported that cyclin A is remarkably decreased in small-cell lung cancer cells by treatment with golvatinib (E7050) [38], which is consistent with the finding in the present study. The gene discussed is CCNA2; the disease is small cell lung carcinoma.